5 Matching Annotations
  1. Mar 2021
  2. www.medrxiv.org www.medrxiv.org
    https://doi.org/10.1101/2020.05.13.20101253
    1
    1. n.parfitt 26 Mar 2021

      Ioannidis, John P. A. (2020) ‘The Infection Fatality Rate of COVID-19 Inferred from Seroprevalence Data’. MedRxiv. https://doi.org/10.1101/2020.05.13.20101253.

      is:preprint lang:en COVID-19 infection fatality seroprevalence data population antibody meta-analysis age estimate speculation big data
    Visit annotations in context

    Tags

    Annotators

    URL

    medrxiv.org/content/10.1101/2020.05.13.20101253v3
  3. www.theatlantic.com www.theatlantic.com
    COVID-19 Cases Are Dropping Fast. Why?
    1
    1. zoe_ikeotuonye 15 Mar 2021

      Thompson, D. (2021, February 17). COVID-19 Cases Are Dropping Fast. Why? The Atlantic. https://www.theatlantic.com/ideas/archive/2021/02/why-covid-19-cases-are-falling-so-fast/618041/

      is:blog lang:en COVID-19 case social distancing shots seroprevalence seasonality pandemic research statistic healthcare population USA decline vaccination vaccine virus
    Visit annotations in context

    Tags

    Annotators

    URL

    theatlantic.com/ideas/archive/2021/02/why-covid-19-cases-are-falling-so-fast/618041/
  4. www.imperial.ac.uk www.imperial.ac.uk
    Report 34 - COVID-19 Infection Fatality Ratio Estimates from Seroprevalence
    1
    1. n.parfitt 15 Mar 2021

      Imperial College London. ‘Report 34 - COVID-19 Infection Fatality Ratio Estimates from Seroprevalence’. Accessed 12 March 2021. http://www.imperial.ac.uk/medicine/departments/school-public-health/infectious-disease-epidemiology/mrc-global-infectious-disease-analysis/covid-19/report-34-ifr/.

      lang:en is:report COVID-19 fatality seroprevalence infection fatality ratio statistic infection antibody modelling population youth elderly false positive policy leadership
    Visit annotations in context

    Tags

    Annotators

    URL

    imperial.ac.uk/mrc-global-infectious-disease-analysis/covid-19/report-34-ifr/
  5. Sep 2020
  6. www.medrxiv.org www.medrxiv.org
    Seroprevalence and correlates of SARS-CoV-2 neutralizing antibodies: Results from a population-based study in Bonn, Germany
    1
    1. ErikStuchly 02 Sep 2020

      Aziz, N. A., Corman, V. M., Echterhoff, A. K. C., Richter, A., Schmandke, A., Schmidt, M. L., Schmidt, T. H., Vries, F. M. D., Drosten, C., & Breteler, M. M. B. (2020). Seroprevalence and correlates of SARS-CoV-2 neutralizing antibodies: Results from a population-based study in Bonn, Germany. MedRxiv, 2020.08.24.20181206. https://doi.org/10.1101/2020.08.24.20181206

      is:preprint lang:en COVID-19 seroprevalence correlate neutralization antibody population-based Germany estimate exposure symptom
    Visit annotations in context

    Tags

    Annotators

    URL

    medrxiv.org/cgi/content/10.1101/2020.08.24.20181206
  7. May 2020
  8. dash.harvard.edu dash.harvard.edu
    Implications of test characteristics and population seroprevalence on ‘immune passport’ strategies
    1
    1. edampf 13 May 2020

      Larremore, Daniel B., Kate M. Bubar, and Yonatan H. Grad. Implications of test characteristics and population seroprevalence on ‘immune passport’ strategies (May 2020).https://dash.harvard.edu/handle/1/42664007

      is:article lang:en COVID-19 immunity passport return to work population seroprevalence testing prevention infection transmission reduction antibody exposure implication
    Visit annotations in context

    Tags

    Annotators

    URL

    dash.harvard.edu/handle/1/42664007